ESTRO Brachytherapy for Prostate Cancer 2018

BUT ALSO:

-Results given in terms of biochemical control ( almost the rule); this biochemical control depends on local control (expected to be related to dose), but also on “distant” control ( this essentially for high-risk patients), with no ( or much less) relation to local dose (?) -The percentage of patients receiving Androgen deprivation therapy (ADT). Large variations from one series to another may introduce a bias in biochemical control in some instances.

-The follow-up , which may be inadequate in some series.

-The narrow range in D90 in most of the modern series

-……………..